Management of Prostate Cancer
2nd Edition
Published on 7. May 2004
XVII, 667 pages
978-1-59259-776-5 (ISBN)
Description
Although much progress has been made in the four years since the first edition of Management of Prostate Cancer, prostate cancer remains a significant biological, me- cal, and personal challenge for millions of men. In this interval, some important trends and observations have emerged that represent real progress in the field and which will shape the direction of clinical practice and research in the next 5-10 years. These obs- vations include: (1) a decline in prostate-related cancer mortality in the United States, likely owing to a combination of factors including screening, more aggressive and earlier therapy, and improvements in specific therapies; (2) a significant downward pathological stage migration, so that an individual's chance of cure for a given stage, grade, and PSA is better now than it was early in the PSA era, even without associated improvements in individual therapies; (3) the recognition of new PSA isoforms that may refine screening strategies; (4) several randomized, phase III clinical trials demonstrating survival adv- tages of one form of therapy over another in selected populations (external beam rad- therapy with adjuvant hormones vs radiotherapy alone, radical prostatectomy vs observation); (5) a focus on the biology of bone and bone metastasis, and new agents that reduce skeletal-related events and which may inhibit the growth of new metastases; (6) second-generation anti-PSMA antibodies with improved potential for imaging and therapy; (7) the development and widespread adoption of nomograms that assist in cli- cal decision-making for individual patients; (8) the identification of new genes that
Reviews / Votes
"...a valued addition to the literature of prostate cancer. All treating these patients should find some value and useful information in this book; it is an important update of the first edition." - Doody's Health Sciences Book Review Journal"This is a valued addition to the literature of prostate cancer. The clinical issues relevant to the disease are appropriately addressed and the book is one of the more current ones available. The authors are well recognized and their opinions in their respective chapters are presented clearly. All treating these patients should find some value and useful information in this book; it is an important update of the first edition." - Doody's Health Sciences Book Review Journal
Reviews of the first edition:
"Presently, early detection and treatment remain our best hope for the cure of this common disease. Dr. Klein has assembled an outstanding group of authors to contribute to Management of Prostate Cancer. Those who take the time to read it will have a much better understanding of the management of prostate cancer."-Foreword by Ralph A. Straffon, MD
"...Klein's Management of Prostate Cancer provides a balanced and comprehensive review...the 20 chapters are well written and provide a balanced view of the issues in diagnosis and treatment. The book's best feature is that it presents both sides of the picture...Thompson and Foley present in a point-counterpoint style arguments that support or refute the effectiveness of screening, the clinical significance of detected disease, and the effectiveness of local treatment, as well as opposing views on cost and the quality of data from prospective trials...A second feature of this book is its practical approach to the management of prostate cancer and the complications of treatment...The third feature of this book is its emphasis on new horizons...Management of Prostate Cancer is an informative review, and most of the chapters should be readily understood by patients and physicians alike. The last two chapters, on the surgeon's and radiation oncologist's perspectives, would be valuable reading for any man with prostate cancer who must decide whether to undergo surgery or radiation therapy. The chapter on screening provides important insights for primary care physicians facing the problem of whether to recommend screening."-The New England Journal of Medicine
"This book is a must read for any physician desiring a complete and up-to-date understanding of prostate cancer. All aspects of this variable, complex, and prevalent disease are discussed in the 20 chapters, with contributions from 43 clinicians involved in the diagnosis and treatment of prostate cancer...Outstanding discussions analyze risk factors and genetic markers...The Management of Prostate Cancer will provide the clinician with a current, complete snapshot of all issues involved in the diagnosis and management of this disease. It should be part of the library of all urologists. Pathologists, radiation oncologists, medical oncologists, surgical oncologists, and general surgeons will find this text very useful as a reference for the latest developments in this field."-Current Surgery
"The book offers recent survey in the field of prostate cancer epidemiology, risk factor, molecular markers, diagnostic procedures (including prostate biopsy), transrectal ultrasonography, computer tomography, magnetic resonance, the techniques of radical prostatectomy, radiotherapy and hormone therapy. Moreover there are on clinical practice oriented chapters, as interpretation of pathological findings, perioperative care, life quality evaluation, posttherapeutical urological disorders and modes of sexual rehabilitation, as well as adequate instructions of surgeon and radiotherapeutist for the period following adequate treatment....This publication represents an outstanding work devoted to the current state-of-the-art of the diagnosis and treatment of cancer, based on molecular-biological technology. It gives a comprehensive view about new achievements in molecular oncology and about innovations in research of human cancers. ...The book can be fully recommended for medical oncologists, surgeons and gynecologists engaged in cancer treatment as a guide in this new rapidly developing topic....The book offers an up-to-date information on prostate cancer diagnostics and treatment and can be fully recommended to all physicians, especially to urologists, radiotherapeutists and oncologists."- Neoplasma
"...this book is a comprehensive and concise update of the current knowledge of prostatic cancer....includes up-to-date information on the evaluation and treatment as well as the molecular biology, epidemiology and pathology of prostate cancer. Surgical treatment, radiation therapy, hormonal therapy, gene therapy and other therapeutic modalities are emphasized. Issues of early detection, quality of life and complications after treatment, and patient counseling are also broadly discussed....The strength of this book lies in its well-balanced and concise review of current diagnostic and therapeutic methods. Most of the illustrations and tables are good, and the references are current....The often ignored topic of hormone refractory prostate cancer is well presented....this book is practical, well illustrated and of value for those who would like to have a better understanding of the management of prostate cancer. It is a worthwhile resource for the general urologist, radiation and urological oncologists as well as for residents in training." - Journal of Urology
"...this book is both timely and useful for all clinicians who wish to obtain a clear and up-to-date account of the management of prostate cancer." - British Journal of Surgery
More details
Other editions
New editions
Eric A. Klein | J. Stephen Jones
Management of Prostate Cancer
E-Book
08/2012
3rd Edition
Humana
€106.99
Available for download
Additional editions
Eric A. Klein
Management of Prostate Cancer
Book
05/2004
2nd Edition
Humana Press Inc.
€85.59
Article exhausted; check for reprint
Previous edition
Eric A. Klein
Management of Prostate Cancer
E-Book
12/1999
1st Edition
Humana
€53.49
Available for download
Content
I. Screening, Risk Factors, Diagnosis, and Prevention.- 1 Prostate Cancer Overdiagnosis and Overtreatment: Analysis of US Mortality and SEER Incidence Trends in the PSA and Pre-PSA Eras.- 2 Total, Complexed, and Free PSA Forms and Human Glandular Kallikrein 2: Clinical Application for Early Detection and Staging of Prostate Cancer.- 3 Defining an Optimum PSA-Based Screening Strategy for Young Men.- 4 Hereditary Prostate Cancer and Genetic Risk.- 5 Strategies for the Chemoprevention of Prostate Cancer.- 6 The Special Problems of Prostate Cancer Among African Americans: Clinical and Molecular Factors.- 7 Current Issues in Pathologic Evaluation.- 8 Current Trends in Biopsy Techniques.- II. Localized Disease: Treatment and Outcomes.- 9 Predicting Outcomes: Artificial Neural Networks and Nomograms.- 10 When Is Observation Appropriate?.- 11 Contemporary Technique of Radical Prostatectomy: Open Approach.- 12 Contemporary Technique of Radical Prostatectomy: Laparoscopic Approach.- 13 Contemporary Technique of Radical Prostatectomy: Perineal Approach.- 14 Anesthetic Considerations for Contemporary Radical Prostatectomy.- 15 Conformal External Beam Radiotherapy.- 16 Brachytherapy.- 17 Androgen Deprivation and Radiation Therapy for Localized Prostate Cancer.- 18 Prostate Brachytherapy: The Role of Supplemental External Beam Radiotherapy.- 19 Health-Related Quality of Life Issues.- 20 The Evaluation and Management of Postprostatectomy Urinary Incontinence.- 21 Sural Nerve Grafting During Radical Prostatectomy: Techniques and Results.- 22 Management of Erectile Dysfunction Following Radical Prostatectomy.- 23 Counseling Patients With Localized Prostate Cancer: Radiation or Surgery?.- 24 Counseling the Patient With Prostate Cancer: The Radiation Oncologist's Perspective.- 25Counseling Patients on Choice of Therapy: The Medical Oncologist's Perspective.- 26 Emotional and Informational Support for the Patient Undergoing Radical Prostatectomy.- 27 Prostate Cancer: A Survivor's View.- 28 Prostate Cancer: A Spouse's View.- III. Advanced Disease.- 29 Management of PSA Recurrence After Definitive Therapy for Prostate Cancer.- 30 When to Refer a Patient With Prostate Cancer to a Medical Oncologist: The Earlier the Better.- 31 Management of Newly Diagnosed Metastatic Disease.- 32 Management of the Patient With Androgen-Independent Metastatic Prostate Cancer.- 33 Bone-Targeted Therapy for Prostate Cancer.- IV. Applied Molecular Biology.- 34 Biology of PSMA As a Diagnostic and Therapeutic Target.- 35 Opportunities for Targeted Molecular Therapy for Prostate Cancer.
